Clinical Trials · NCT02073929
LIPT - Liraglutide in Polycystic Ovary Syndrome
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Jens Faber
- Enrollment
- 72
- Start date
- Mar 2014
- Locations
- 3 sites, Denmark
- Primary endpoint
- Change in Endogenous Thrombin Potential (ETP)